Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Levodopa-Induced Dyskinesia in Parkinson's Disease
NCT00296959Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in levodopa-induced dyskinesia (LID), sponsored by University Health Network. Started Sep 2004; status: terminated.
02
Drugs
topiramate
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00296959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296959.